pharmaceutical costs

Five things to know about Trump’s FDA lead pick GottliebOn March 10, the White House announced that President Donald Trump selected Scott Gottlieb, MD, who has worked for FDA in the past, as his choice to head the FDA. Here are five things managed healthcare executives should know about the pick.
Opinion: More industry-stakeholders play blame game for high drug costsOur policy analyst weighs in on a new drug industry PR campaign that attempts to shift the blame for high drug costs.
Independent Pharmacy Cooperative and Pace Alliance Join Together
Independent Pharmacy Cooperative and Pace Alliance Join TogetherIPC and Pace Alliance join together to help the independent pharmacist.
New diabetes medications help address linked diseasesExperts share updates on new diabetes medications, and provide an overview of what’s coming.
Watch list 2017: Top therapeutic areas
Watch list 2017: Top therapeutic areasFind out about the latest treatment and drug pipeline developments
Top pharmacy challenges of 2017
Top pharmacy challenges of 2017High drug prices continue to plague payers, but various contributing factors intensify the problem.
Will new autoimmune drugs address cost concerns?Find out what’s in the drug pipeline for autoimmune disease.
Top 2017 challenges healthcare executives face
Top 2017 challenges healthcare executives faceResults from Managed Healthcare Executive’s annual State of the Industry Survey reveal which issues will hit managed healthcare hardest in 2017.
Four innovative models rein in pharma costs
Four innovative models rein in pharma costsPlans and PBMs are finding new ways to rein in pharmacy costs.
Online drug pricing tools that influence consumers
Online drug pricing tools that influence consumersConsumers are demanding transparency in the prices of drugs. Here’s how they are getting it.